Spironolactone Reduces Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension: a Preliminary Report

INTRODUCTION: Obstructive sleep apnea (OSA) and hyperaldosteronism are very common in subjects with resistant hypertension. We hypothesized that aldosterone mediated chronic fluid retention may influence OSA severity in patients with resistant hypertension. We tested this in an open label evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaddam, Krishna, Pimenta, Eduardo, Thomas, S. Justin, Cofield, Stacey S, Oparil, Suzanne, Harding, Susan M., Calhoun, David A
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891919/
https://www.ncbi.nlm.nih.gov/pubmed/20016520
http://dx.doi.org/10.1038/jhh.2009.96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891919/
https://www.ncbi.nlm.nih.gov/pubmed/20016520
http://dx.doi.org/10.1038/jhh.2009.96

Ejemplares similares